The global Acute Kidney Injury (AKI) Treatment Market is poised for significant growth, with a projected CAGR of 8.2% during the forecast period from 2022 to 2029. The market, valued at USD 2,058.2 million in 2022, is expected to surpass USD 3,566.7 million by the end of 2029, driven by the increasing prevalence of kidney-related disorders and advancements in therapeutic solutions.
The surge in demand for acute kidney injury treatment is attributed to a rise in chronic conditions such as diabetes and hypertension, which are major risk factors for AKI. Furthermore, the growing geriatric population, coupled with increasing incidences of hospital-acquired acute kidney injury, underscores the need for effective treatment options.
Market players are focusing on innovative therapies, advanced dialysis techniques, and novel pharmaceuticals to improve patient outcomes. The emphasis on early detection and personalized medicine is also driving the development of cutting-edge solutions in the AKI treatment landscape.
Key Takeaways:
- The AKI Treatment Market is anticipated to grow at a CAGR of 8.2%, with the market valuation increasing from USD 2,058.2 million in 2022 to USD 3,566.7 million by 2029.
- Key drivers include rising cases of chronic illnesses such as diabetes and hypertension and the growing prevalence of hospital-acquired AKI.
- Innovative therapies and advanced dialysis solutions are central to the market’s evolution, ensuring better patient outcomes.
- Early detection and personalized medicine are becoming increasingly important in addressing the global AKI burden.
This robust growth trajectory highlights the urgent need for advanced and accessible treatment options, as healthcare systems worldwide work to mitigate the impact of acute kidney injury on patients’ lives.
Request a Sample of this Report Now: https://www.fmisamplereport.com/sample/rep-gb-14403
Key Factors Driving Market Growth
- Increasing Incidence of AKI: The rising prevalence of acute kidney injury, often associated with chronic diseases such as diabetes and hypertension, is a major driver behind the demand for effective treatment solutions.
- Aging Population: As the global population ages, the incidence of AKI is expected to rise, leading to greater demand for treatment options.
- Advancements in Healthcare Infrastructure: Improvements in healthcare facilities and technologies are facilitating better diagnosis and treatment of AKI.
- Growing Awareness: Increased awareness regarding kidney health and the importance of early detection and management of AKI is contributing to market growth.
Market Insights
- The market includes various treatment modalities such as drug therapy, dialysis (both intermittent and continuous), and supportive care measures tailored to manage AKI effectively.
- Regional Trends: North America is expected to dominate the market due to advanced healthcare systems and significant investments in kidney disease management. Meanwhile, the Asia Pacific region is projected to exhibit the fastest growth rate due to a large patient population and increasing healthcare expenditures.
Competitive Landscape
Leading players in the global acute kidney injury treatment market are focusing on developing automated, portable, and tech-driven dialysis equipment to deliver advanced care to patients. They are also integrating advanced technologies such as artificial intelligence and the Internet of Things (IoT) to expand their product portfolio.
Meanwhile, some of the other players are making advancements in diagnostic technology in order to streamline their product offerings in emerging economies with diverse product portfolios.
For instance:
- In March 2021, C-Path announced the launch of an acute kidney injury project in partnership with the USA Food and Drug Administration (FDA) for Drug Evaluation and Research, the Office of translational science, and the Division of cardiology and Nephrology, to develop a suite of prognostic tools to improve the detection of drug-induced kidney injury.
- In June 2021, Abionyxx announced the enrollment of the first patient in its Phase-2a clinical study with CER-001 for the treatment of septic patients at high risk of developing acute kidney injury.
Key Companies Profiled
Novartis, Pfizer Inc.; Merck & Co.; Biocon Ltd.; Teva Pharmaceutical Industries Ltd.; Mylan Pharmaceuticals Inc.; NIPRO Medical; Baxter Corporation; Asahi Kasei; NIKKISO; Fresenius Medical Care; Others
Acute Kidney Injury Treatment Market By Category
Product:
- Dialysis
- Intermittent Hemodialysis
- Continuous Renal Replacement Therapy (CRRT)
- Sustained Low-Efficiency Dialysis (SLED)
- Drug Therapy
- Antibiotics
- Diuretics
- Immunosuppressive Agents
Injury:
- Pre-renal Injury
- Intrinsic Renal Injury
- Post-renal Injury
Distribution Channel:
- Hospitals
- Ambulatory Surgical Centers
- Others
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa(MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube